![Ann J. Barbier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ann J. Barbier
Directeur/Membre du Conseil chez
VICORE PHARMA HOLDING AB
Fortune : 55 331 $ au 30/06/2026
Profil
Ann J.
Barbier currently works at Vicore Pharma Holding AB, as Director from 2024.
Dr. Barbier also formerly worked at Shire Human Genetic Therapies, Inc., as Senior Director-Medical from 2007 to 2011, Pieris Pharmaceuticals, Inc., as Independent Director from 2018 to 2024, Agios Pharmaceuticals, Inc., as Vice President-Clinical Development from 2015 to 2017, Translate Bio, Inc., as Chief Medical Officer from 2017 to 2021, Shire Pharmaceuticals, Inc., as Global Lead-Clinical Development from 2014 to 2015, and CAMP4 Therapeutics Corp., as Chief Medical Officer from 2022 to 2023.
Dr. Barbier received her doctorate degree in 1985 from Ghent University and graduate degree in 1995 from Université Libre de Bruxelles.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 42 500 ( 0,02% ) | 55 331 $ | 30/06/2026 |
Postes actifs de Ann J. Barbier
| Sociétés | Poste | Début |
|---|---|---|
| VICORE PHARMA HOLDING AB | Directeur/Membre du Conseil | 07/05/2024 |
Anciens postes connus de Ann J. Barbier
| Sociétés | Poste | Fin |
|---|---|---|
| PIERIS PHARMACEUTICALS | Directeur/Membre du Conseil | 13/12/2024 |
| CAMP4 THERAPEUTICS CORPORATION | Directeur Technique/Scientifique/R&D | 01/10/2023 |
| TRANSLATE BIO, INC. | Directeur Technique/Scientifique/R&D | 14/09/2021 |
| AGIOS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2017 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Technique/Scientifique/R&D | 01/05/2015 |
Formation de Ann J. Barbier
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Vicore Pharma Holding AB
 Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
